CT-guided radiofrequency ablation for osteoid osteomas: a systematic review
- 9 June 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 30 (11), 5952-5963
- https://doi.org/10.1007/s00330-020-06970-y
Abstract
Objectives CT-guided radiofrequency ablation (CT-RFA) is considered to be the gold standard for treatment of osteoid osteoma (OO) yet treatment failures (TFs) continue to be reported. This systematic review was conducted to evaluate factors associated with TF, such as ablation time, lesion location, and patient age as well as evaluating how TF has trended over time. Methods Original studies reporting on patients undergoing CT-RFA of OO published between 2002 and 2019 were identified. TF was defined as patients with (1) recurrent or persistent pain +/− (2) imaging evidence of persistent OO. TFs were subdivided into those occurring after the index procedure (primary TF) or those occurring after repeat RFA (secondary TF). Subgroup analysis was performed for TF based on the study date (2002–2010 or 2010–2019), time duration of ablation at 90 °C (6 min or > 6 min), patient age, and tumor location (spinal vs. appendicular). Results Sixty-nine studies were included for a total of 3023 patients. The global primary TF rate was 8.3% whereas the secondary TF rate was 3.1%. The TF rate reported in studies published after 2011(7%) was about half that during the earlier time period 2002–2010 (14%). There was no statistical difference in TF corrected for age, OO location, or duration of ablation (respectively p = 0.39, 0.13, and 0.23). The global complication rate was 3%, the most frequent being skin burns (n = 24; 0.7%). Conclusions A decrease in TF observed between 2011–2019 compared to 2002–2010 may reflect improvements in operator technique or advancements in equipment. Duration of ablation, patient age, or location of OO failed to significantly correlate with TF. Key Points • CT-guided radiofrequency ablation of osteoid osteomas is a safe technique with a low rate of treatment failure (8.3% failure rate after the primary radiofrequency reducing to 3.1% following a secondary treatment). • The treatment failure rate has decreased over time, possibly due to an improved understanding of the disease process, better technique, and advances in equipment. • Duration of ablation, patient age, or lesion location did not significantly correlate with treatment failure.This publication has 85 references indexed in Scilit:
- CT-guided radiofrequency ablation of osteoid osteoma in the long bones of the lower extremityWorld Journal of Radiology, 2012
- Follow-up of thirty-three computed-tomography-guided percutaneous radiofrequency thermoablations of osteoid osteomaInternational Orthopaedics, 2011
- Osteoid Osteoma: Can Impedance Levels in Radiofrequency Thermocoagulation Predict Recurrence?Radiology Research and Practice, 2010
- Radiofrequency Ablation of Osteoid Osteoma in Atypical Locations: A Case SeriesClinical Orthopaedics and Related Research, 2010
- Weighting by Inverse Variance or by Sample Size in Random-Effects Meta-AnalysisEducational and Psychological Measurement, 2009
- Computed-tomography-guided percutaneous radiofrequency thermoablation for the treatment of osteoid osteoma—2 to 5 years follow-upInternational Orthopaedics, 2007
- Osteoid Osteoma: CT-Guided Radiofrequency Ablation Using a Water-Cooled ProbeAnnals of Surgical Oncology, 2006
- Percutaneous computed tomography-guided radiofrequency ablation of osteoid osteomasEuropean Journal of Orthopaedic Surgery & Traumatology, 2006
- Radiofrequency Ablation of Osteoid Osteoma in the Upper ExtremityThe Journal of Hand Surgery, 2006